Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Total Liabilities 2020–2025
Fulcrum Therapeutics Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Fulcrum Therapeutics Inc. total liabilities as of December 31, 2025: 17.3M, a 2.26% decrease year-over-year.
- Fulcrum Therapeutics Inc. total liabilities for 2025 were 17.3M, a 2.26% decrease from 2024.
- Fulcrum Therapeutics Inc. total liabilities for 2024 were 17.7M, a 21.41% decrease from 2023.
- Fulcrum Therapeutics Inc. total liabilities for 2023 were 22.5M, a 18.89% decrease from 2022.
- Fulcrum Therapeutics Inc. total liabilities for 2022 were 27.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fulcrum Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $18 |
| 2023 | $23 |
| 2022 | $28 |
| 2021 | $23 |
| 2020 | $34 |
Fulcrum Therapeutics Inc. Total Liabilities — FAQ
Fulcrum Therapeutics Inc. (FULC) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FULC's total liabilities history?
The chart and table above show Fulcrum Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.